nimustine has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, YJ; Li, YL; Luo, W; Xiang, Q | 1 |
| Nakasu, S; Saito, A; Suda, K | 1 |
2 other study(ies) available for nimustine and Day Blindness
| Article | Year |
|---|---|
High dose of nimustine as an add-on treatment for small cell lung cancer with intracranial metastasis: A case report and literature review.
Topics: Aged; Antineoplastic Agents; Antineoplastic Protocols; Brain; Brain Neoplasms; Chemoradiotherapy; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Male; Neoplasm Staging; Neurologic Examination; Nimustine; Small Cell Lung Carcinoma; Treatment Outcome; Vision Disorders | 2017 |
Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption.
Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Carotid Arteries; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Mannitol; Middle Aged; Nimustine; Nitrosourea Compounds; Oligodendroglioma; Ophthalmoplegia; Vision Disorders | 1985 |